These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 1505645)

  • 1. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
    Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
    Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
    Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
    Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
    Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
    Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
    Tai ES; Koay ES; Chan E; Seng TJ; Loh LM; Sethi SK; Tan CE
    Clin Chem; 2001 Mar; 47(3):438-43. PubMed ID: 11238294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
    Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
    Morash B; Guernsey DL; Tan MH; Dempsey G; Nassar BA
    Clin Biochem; 1994 Aug; 27(4):265-72. PubMed ID: 8001287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Pimstone SN; Defesche JC; Clee SM; Bakker HD; Hayden MR; Kastelein JJ
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Miserez AR; Keller U
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
    Ejarque I; Real JT; Martinez-Hervas S; Chaves FJ; Blesa S; Garcia-Garcia AB; Millan E; Ascaso JF; Carmena R
    Transl Res; 2008 Mar; 151(3):162-7. PubMed ID: 18279815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100.
    Hansen PS; Meinertz H; Jensen HK; Fruergaard P; Launbjerg J; Klausen IC; Lemming L; Gerdes U; Gregersen N; Faergeman O
    Arterioscler Thromb; 1994 Feb; 14(2):207-13. PubMed ID: 8305410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of an exon 3 mutation (Trp66-->Gly) of the LDL receptor with variable expression of familial hypercholesterolemia in a French Canadian family.
    Levy E; Minnich A; Cacan SL; Thibault L; Giroux LM; Davignon J; Lambert M
    Biochem Mol Med; 1997 Feb; 60(1):59-69. PubMed ID: 9066982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D; Schuster H; Zöllner N
    Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification and characterization of the first Spanish familial ligand-defective apolipoprotein B homozygote].
    Ejarque I; Civer M; Francisco Ascaso J; Knecht E; Eugenia Armengod M; Carmen R; Tomás Real J; Francisco Chaves J; Javier Martín De Llano J
    Med Clin (Barc); 2001 Feb; 116(4):138-41. PubMed ID: 11222161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.
    Rubinsztein DC; Raal FJ; Seftel HC; Pilcher G; Coetzee GA; van der Westhuyzen DR
    Arterioscler Thromb; 1993 Jul; 13(7):1076-81. PubMed ID: 8318509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the apo B-3500 mutation in the Norwegian population.
    Leren TP; Rødningen OK; Tonstad S; Røsby O; Urdal P; Ose L
    Scand J Clin Lab Invest; 1995 May; 55(3):217-21. PubMed ID: 7638555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
    Myant NB
    Atherosclerosis; 1993 Dec; 104(1-2):1-18. PubMed ID: 8141833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the apolipoprotein (apo) B-100 receptor-binding region: detection of apo B-100 (Arg3500-->Trp) associated with two new haplotypes and evidence that apo B-100 (Glu3405-->Gln) diminishes receptor-mediated uptake of LDL.
    Fisher E; Scharnagl H; Hoffmann MM; Kusterer K; Wittmann D; Wieland H; Gross W; März W
    Clin Chem; 1999 Jul; 45(7):1026-38. PubMed ID: 10388479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.